Form 4: Precipio Director Kathleen LaPorte Granted Stock Options

Precipio, Inc. Director Kathleen LaPorte received 1,500 stock options with an exercise price of $23.82, vesting monthly over one year.

Summary

• Kathleen LaPorte, a Director of Precipio, Inc. (PRPO), was granted 1,500 stock options.
• The options have an exercise price of $23.82 per share.
• The grant date for these options was January 2, 2026.
• The options will vest in twelve equal monthly installments, starting one month after the issuance date.
• The expiration date for these options is January 2, 2036.
• The grant was made under the Issuer's Equity Incentive Plan as compensation for her service as a director.

Sentiment

Score: 7

Explanation: The filing reports a standard director compensation event, which is generally positive for aligning management and shareholder interests, without indicating any significant operational or financial changes.

Positives

• The grant of stock options to Director Kathleen LaPorte aligns her interests with those of shareholders, incentivizing long-term company performance.

Negatives

• The issuance of stock options, upon exercise, could lead to a minor dilution of existing shares, though this is a standard practice for executive and director compensation.

Risks

• The value of the stock options is dependent on the future market price of Precipio, Inc. common stock exceeding the exercise price of $23.82.
• Potential for dilution if all options are exercised.

Future Outlook

The stock options are designed to vest over twelve equal monthly installments, beginning one month after the grant date, aligning future compensation with continued service.

Management Comments

• The stock option was granted pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer.

Industry Context

The grant of stock options to a director is a common practice in the biotechnology and healthcare industry, aiming to align the interests of board members with long-term shareholder value creation.

Comparison to Industry Standards

• The grant of 1,500 stock options to a director is within typical ranges for non-executive director compensation in small-cap biotechnology companies, often used to attract and retain qualified board members.

Corporate Governance

Related Party Transactions

• Grant of 1,500 stock options to Kathleen LaPorte, a director of Precipio, Inc., as compensation for her service.

Stakeholder Impact

• Shareholders: Interests are aligned with the director through equity compensation, potentially leading to better long-term performance.

Next Steps

• The stock options will begin vesting in twelve equal monthly installments starting one month after January 2, 2026.

Key Dates

Keywords

Precipio, PRPO, Stock Option, Director Compensation, Form 4, Equity Incentive Plan, Kathleen LaPorte